Tozorakimab (anti-IL-33) (C007B-552791)

Catalog No.: C007B-552791
Mfr. No.: Ab182933-100μg
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $103.67

List Price: $115.19

Tozorakimab (anti-IL-33) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab (anti-IL-33) reduces inflammation and epithelial dysfunction.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Tozorakimab (anti-IL-33) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab (anti-IL-33) reduces inflammation and epithelial dysfunction. Tozorakimab (anti-IL-33) can be used to research chronic obstructive pulmonary disease.Purity≥95%(SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg

Specification: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot

Molecular Formula: CH3

Molecular Weight: 15.03

Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182933-SCI_8c4e99c5727c737c819dcc6c1883bec6.pdf

UPC:: 51381508
Condition:: New
Availability:: 5-10 days
Weight:: 0.07 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: Ab182933-100μg
CAS:: 2376858-66-9
Product Size:: 100μg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."